APRE
Price
$0.64
Change
-$0.03 (-4.48%)
Updated
Feb 5, 02:23 PM (EDT)
Capitalization
4.63M
Intraday BUY SELL Signals
RZLT
Price
$2.92
Change
+$0.01 (+0.34%)
Updated
Feb 5, 03:46 PM (EDT)
Capitalization
269.84M
6 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APRE vs RZLT

Header iconAPRE vs RZLT Comparison
Open Charts APRE vs RZLTBanner chart's image
Aprea Therapeutics
Price$0.64
Change-$0.03 (-4.48%)
Volume$279
Capitalization4.63M
Rezolute
Price$2.92
Change+$0.01 (+0.34%)
Volume$7.3K
Capitalization269.84M
APRE vs RZLT Comparison Chart in %
APRE
Daily Signal:
Gain/Loss:
RZLT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APRE vs. RZLT commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRE is a Hold and RZLT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (APRE: $0.67 vs. RZLT: $2.91)
Brand notoriety: APRE and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APRE: 16% vs. RZLT: 29%
Market capitalization -- APRE: $4.63M vs. RZLT: $269.84M
APRE [@Biotechnology] is valued at $4.63M. RZLT’s [@Biotechnology] market capitalization is $269.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APRE’s FA Score shows that 2 FA rating(s) are green whileRZLT’s FA Score has 1 green FA rating(s).

  • APRE’s FA Score: 2 green, 3 red.
  • RZLT’s FA Score: 1 green, 4 red.
According to our system of comparison, APRE is a better buy in the long-term than RZLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APRE’s TA Score shows that 4 TA indicator(s) are bullish while RZLT’s TA Score has 4 bullish TA indicator(s).

  • APRE’s TA Score: 4 bullish, 4 bearish.
  • RZLT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, APRE is a better buy in the short-term than RZLT.

Price Growth

APRE (@Biotechnology) experienced а -12.32% price change this week, while RZLT (@Biotechnology) price change was -13.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

RZLT is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RZLT($270M) has a higher market cap than APRE($4.63M). RZLT YTD gains are higher at: 23.305 vs. APRE (-21.454). APRE has higher annual earnings (EBITDA): -13.8M vs. RZLT (-82.74M). RZLT has more cash in the bank: 152M vs. APRE (13.7M). APRE has less debt than RZLT: APRE (0) vs RZLT (1.45M). APRE (0) and RZLT (0) have equivalent revenues.
APRERZLTAPRE / RZLT
Capitalization4.63M270M2%
EBITDA-13.8M-82.74M17%
Gain YTD-21.45423.305-92%
P/E RatioN/AN/A-
Revenue00-
Total Cash13.7M152M9%
Total Debt01.45M-
FUNDAMENTALS RATINGS
APRE vs RZLT: Fundamental Ratings
APRE
RZLT
OUTLOOK RATING
1..100
9381
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9463
P/E GROWTH RATING
1..100
5100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APRE's Valuation (14) in the null industry is in the same range as RZLT (21). This means that APRE’s stock grew similarly to RZLT’s over the last 12 months.

APRE's Profit vs Risk Rating (100) in the null industry is in the same range as RZLT (100). This means that APRE’s stock grew similarly to RZLT’s over the last 12 months.

APRE's SMR Rating (98) in the null industry is in the same range as RZLT (98). This means that APRE’s stock grew similarly to RZLT’s over the last 12 months.

RZLT's Price Growth Rating (63) in the null industry is in the same range as APRE (94). This means that RZLT’s stock grew similarly to APRE’s over the last 12 months.

APRE's P/E Growth Rating (5) in the null industry is significantly better than the same rating for RZLT (100). This means that APRE’s stock grew significantly faster than RZLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APRERZLT
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 28 days ago
77%
Bullish Trend 14 days ago
90%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APRE
Daily Signal:
Gain/Loss:
RZLT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACIC11.180.11
+0.99%
American Coastal Insurance Corp
WF65.310.39
+0.60%
Woori Financial Group
KNTK41.280.03
+0.07%
Kinetik Holdings
HSDT2.22-0.11
-4.72%
Solana Company
ULY1.97-0.44
-18.26%
Urgently Inc.

APRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APRE has been closely correlated with MREO. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if APRE jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APRE
1D Price
Change %
APRE100%
-0.49%
MREO - APRE
69%
Closely correlated
-2.73%
BCAB - APRE
66%
Loosely correlated
+11.06%
LENZ - APRE
66%
Loosely correlated
-5.86%
RZLT - APRE
65%
Loosely correlated
-7.62%
CALC - APRE
65%
Loosely correlated
+8.37%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been closely correlated with QNCX. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if RZLT jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
-7.62%
QNCX - RZLT
83%
Closely correlated
+9.28%
TPST - RZLT
82%
Closely correlated
-1.24%
BCAB - RZLT
79%
Closely correlated
+11.06%
GNTA - RZLT
75%
Closely correlated
-1.27%
BDRX - RZLT
73%
Closely correlated
-11.04%
More